Literature DB >> 3471370

Classification of the myelodysplastic syndromes.

J M Bennett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3471370

Source DB:  PubMed          Journal:  Clin Haematol        ISSN: 0308-2261


× No keyword cloud information.
  10 in total

Review 1.  The pathology of autoimmune haemolytic anaemia.

Authors:  R J Sokol; D J Booker; R Stamps
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

2.  Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency.

Authors:  P D Cotter; M Baumann; D F Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes.

Authors:  R J Sokol; S Hewitt; D J Booker
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

4.  Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.

Authors:  Elaine M Sloand; Lori Mainwaring; Monika Fuhrer; Shakti Ramkissoon; Antonio M Risitano; Keyvan Keyvanafar; Jun Lu; Atanu Basu; A John Barrett; Neal S Young
Journal:  Blood       Date:  2005-04-12       Impact factor: 22.113

5.  Immunohistochemical study of T lymphocyte subsets on frozen substituted plastic embedding section of the bone marrow from patients with myelodysplastic syndrome and its clinical implication.

Authors:  S Liu; X Liu; P Zou; S Song; B Wang
Journal:  J Tongji Med Univ       Date:  1999

6.  Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis.

Authors:  H Maschek; V Kaloutsi; M Rodriguez-Kaiser; M Werner; H Choritz; K Mainzer; M Dietzfelbinger; A Georgii
Journal:  Ann Hematol       Date:  1993-03       Impact factor: 3.673

7.  Human deep tissue infection with an entomopathogenic Beauveria species.

Authors:  Markus Oliver Henke; G Sybren De Hoog; Uwe Gross; Gisbert Zimmermann; Doris Kraemer; Michael Weig
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

8.  Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.

Authors:  P D Cotter; A May; E J Fitzsimons; T Houston; B E Woodcock; A I al-Sabah; L Wong; D F Bishop
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

9.  Myeloid leukaemia following therapy for a first primary cancer.

Authors:  A Nandakumar; S Davis; S Moolgavkar; R P Witherspoon; S M Schwartz
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

10.  Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.

Authors:  Azra Raza; Naomi Galili; Natalie Callander; Leonel Ochoa; Lawrence Piro; Peter Emanuel; Stephanie Williams; Howard Burris; Stefan Faderl; Zeev Estrov; Peter Curtin; Richard A Larson; James G Keck; Marsha Jones; Lisa Meng; Gail L Brown
Journal:  J Hematol Oncol       Date:  2009-05-13       Impact factor: 17.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.